IMN || Infectious Diseases

FDA report provides overview of HCV drug approvals

In a report published in Hepatology, scientists from the FDA’s Division of Antiviral Products in the Center for Drug Evaluation and Research (CDER) have provided a brief overview of the FDA’s...

Field of Interest: Gastroentero...
Type: News Item

Shortening all-oral HCV therapy feasible

VIENNA – All-oral HCV therapy with grazoprevir and elbasvir plus sofosbuvir achieved high, sustained virologic response (SVR) rates at 12 weeks afte... More »

Field of Interest: Gastroentero...
Type: News Item

Pages

Subscribe to RSS - IMN || Infectious Diseases